Versant Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.9K | Sell |
432
-1,161
| -73% | -$32K | ﹤0.01% | 1809 |
|
|
2025
Q1 | $45.2K | Buy |
1,593
+1,280
| +409% | +$36.3K | 0.01% | 909 |
|
|
2024
Q4 | $13K | Buy |
313
+196
| +168% | +$8.15K | ﹤0.01% | 1270 |
|
|
2024
Q3 | $7.82K | Sell |
117
-63
| -35% | -$4.21K | ﹤0.01% | 1146 |
|
|
2024
Q2 | $21.4K | Buy |
180
+129
| +253% | +$15.3K | 0.01% | 687 |
|
|
2024
Q1 | $5.44K | Buy |
51
+10
| +24% | +$1.07K | ﹤0.01% | 999 |
|
|
2023
Q4 | $4.08K | Buy |
41
+3
| +8% | +$298 | ﹤0.01% | 1039 |
|
|
2023
Q3 | $3.93K | Buy |
38
+17
| +81% | +$1.76K | ﹤0.01% | 1061 |
|
|
2023
Q2 | $2.55K | Sell |
21
-1
| -5% | -$122 | ﹤0.01% | 1286 |
|
|
2023
Q1 | $3.36K | Sell |
22
-1
| -4% | -$153 | ﹤0.01% | 1092 |
|
|
2022
Q4 | $4.13K | Sell |
23
-341
| -94% | -$61.2K | ﹤0.01% | 946 |
|
|
2022
Q3 | $43K | Sell |
364
-29
| -7% | -$3.43K | 0.02% | 247 |
|
|
2022
Q2 | $56K | Buy |
393
+28
| +8% | +$3.99K | 0.02% | 204 |
|
|
2022
Q1 | $63K | Sell |
365
-13
| -3% | -$2.24K | 0.02% | 213 |
|
|
2021
Q4 | $96K | Sell |
378
-9
| -2% | -$2.29K | 0.03% | 162 |
|
|
2021
Q3 | $149K | Buy |
387
+366
| +1,743% | +$141K | 0.05% | 120 |
|
|
2021
Q2 | $5K | Buy |
21
+6
| +40% | +$1.43K | ﹤0.01% | 909 |
|
|
2021
Q1 | $2K | Buy |
+15
| New | +$2K | ﹤0.01% | 1254 |
|